Net gamma exposure for Gilead Sciences Inc (GILD) options was positive at the Nov 4, 2026 close, about $19.78M per 1% move in the stock. It has been positive on 20 of the last 20 trading days. With positive gamma, dealer hedging tends to lean against price moves, which can dampen swings.
Upgrade to unlock Gamma Flip, Gamma Profile, Call Wall, Put Wall, and multiple expiration dates.
Gamma Exposure by Strike
Showing results for GILD, 2026-11-06(w), calls & puts
Gamma Exposure Stats
Showing results for GILD, 2026-11-06(w), calls & puts
Net Gamma Exposure by Expiration
Showing results for GILD, 2026-11-06(w), calls & puts. View all expiries
| Expiration | Net GEX | Call GEX | Put GEX | Call Wall | Put Wall | Gamma Flip |
|---|
GILD Gamma Exposure FAQ
What is gamma exposure (GEX)?
Gamma exposure estimates how much stock option dealers must buy or sell to stay hedged for each 1% move in the underlying.
Is GILD gamma exposure positive or negative?
Gilead Sciences net gamma exposure was positive on Nov 4, 2026, at $19.78M. It has been positive on 20 of the last 20 trading days.
How has GILD gamma exposure changed recently?
Gilead Sciences net gamma exposure went from $15.4M on Oct 7, 2026 to $19.78M on Nov 4, 2026. See the GILD gamma exposure history for a longer view.
What is Gilead Sciences Inc?
Gilead Sciences develops and markets therapies to treat and prevent life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C.